RxDoctor Payments Data

Sally Beazlie-Walker, DO

Family Medicine · Plymouth, INNPI 1437312980

Payments from drug & device makers

$989in general payments, 2019–2025

Across 54 payments — averaging $18.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$371
  • GSK$104
  • Pfizer$85
  • Biohaven Pharmaceuticals, Inc.$64
  • AstraZeneca$44
  • Amgen$38
  • plus $283 from 14 others

What the payments were for

  • Food & beverage$96197%
  • Education$283%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$989 in reported general payments places this provider in the 60th percentile of 2,709 family medicine providers in Indiana.

See all family medicine providers in Indiana

Medicare billing

Part B allowed, 2024
$128,094
Medicare patients
217
Services billed
3,295

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide49$63,312
TrulicityDulaglutide26$32,228
JardianceEmpagliflozin28$30,671
Repatha SyringeEvolocumab11$6,525
Stiolto RespimatTiotropium Br/Olodaterol Hcl11$5,077
Lantus SolostarInsulin Glargine,hum.Rec.Anlog17$2,448
Fluticasone-SalmeterolFluticasone Propion/Salmeterol13$2,003
Albuterol Sulfate HfaAlbuterol Sulfate57$1,739
Levothyroxine Sodium141$1,638
SynthroidLevothyroxine Sodium23$1,439
Losartan Potassium173$1,229
Atorvastatin Calcium178$1,227
Rosuvastatin Calcium149$1,149
Venlafaxine Hcl ErVenlafaxine Hcl18$1,071
Metoprolol Succinate74$1,070

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$29$63,31249 claims
Boehringer IngelheimJardiance, Stiolto Respimat$34$35,74839 claims
Lilly USA, LLCTrulicity$19$32,22826 claims
AbbVieSynthroid$371$1,43923 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 2,709 family medicine providers in Indiana.

Other family medicine in Plymouth

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →